(Q43811117)

27 November 2017

title

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). (English)

1 reference

27 November 2017

J A Garcia-Velasco

1

1 reference

27 November 2017

V Isaza

2

1 reference

27 November 2017

C Vidal

3

1 reference

27 November 2017

A Landazábal

4

1 reference

27 November 2017

J Remohí

5

1 reference

27 November 2017

C Simón

6

1 reference

27 November 2017

A Pellicer

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

16

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

2533-2539

1 reference

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomized in-vitro fertilization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Human chorionic gonadotrophin and steroid concentrations in follicular fluid: the relationship to oocyte maturity and fertilization rates in stimulated and natural in-vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Extrapituitary Action of Gonadotropin-Releasing Hormone: Direct Inhibition Ovarian Steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Intraovarian markers of follicular and oocyte maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Intragonadal regulation of follicular maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

Gonadotropin releasing hormone agonists stimulate meiotic maturation of follicle-enclosed rat oocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2533

10.1093/HUMREP/16.12.2533

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference